Results 91 to 100 of about 63,195 (230)

Left ventricular non-compaction: clinical features and cardiovascular magnetic resonance imaging [PDF]

open access: yes, 2009
Background: It is apparent that despite lack of family history, patients with the morphological characteristics of left ventricular non-compaction develop arrhythmias, thrombo-embolism and left ventricular dysfunction.
A Keren   +32 more
core   +5 more sources

ICD for Sudden Cardiac Death Prevention and New Pharmaceutical Treatment Options in Hypertrophic Obstructive Cardiomyopathy

open access: hybrid, 2023
Antônio da Silva Menezes   +7 more
openalex   +2 more sources

A case report of a Chinese patient with obstructive hypertrophic cardiomyopathy harboring rare variants in both the MYBPC3 and DSP genes

open access: yesFrontiers in Cardiovascular Medicine
Hypertrophic cardiomyopathy (HCM) represents the most prevalent form of hereditary cardiomyopathy, and mutation in the cardiac myosin-binding protein C (MYBPC3) gene have been identified as a major contributor to the pathogenesis of HCM.
Xiao-Yuan Wu, Ning Ren, Jie Geng
doaj   +1 more source

Exercise-induced left septal fascicular block: an expression of severe myocardial ischemia [PDF]

open access: yes, 2006
The electrocardiogram (ECG) criteria for the left septal fascicular block (LSFB) are not universally accepted and many other denominations can be seen in literature: focal septal block, septal focal block, left septal fascicular block, left anterior ...
Ferreira, Beatriz Moreira Ayub   +3 more
core   +2 more sources

Late systolic click in non-obstructive cardiomyopathy [PDF]

open access: bronze, 1970
Edward N. Mercer   +2 more
openalex   +1 more source

Eighteen‐Month Real‐World Experience Using Mavacamten for Treatment of Obstructive Hypertrophic Cardiomyopathy in a Racially Diverse Population

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Patients with obstructive hypertrophic cardiomyopathy have increased symptomatic burden. Mavacamten was recently approved for treatment of obstructive hypertrophic cardiomyopathy based on 2 randomized controlled trials.
Diego Ramonfaur   +9 more
doaj   +1 more source

Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality? [PDF]

open access: bronze, 2019
Anita Nguyen   +7 more
openalex   +1 more source

Hypertrophic Obstructive Cardiomyopathy Masked by Tako-Tsubo Syndrome: A Case Report

open access: yesCase Reports in Cardiology, 2012
Introduction. Left ventricular outflow obstruction might be part of the pathophysiological mechanism of Tako-tsubo cardiomyopathy. This obstruction can be masked by Tako-tsubo cardiomyopathy and diagnosed only by followup. Case Presentation.
Y. Daralammori   +5 more
doaj   +1 more source

Right Ventricle Outflow Obstruction in Biventricular Hypertrophic Cardiomyopathy in Amyloidosis

open access: yesEuropean Journal of Case Reports in Internal Medicine, 2017
Light-chain (AL) amyloidosis is the most common type of amyloidosis; cardiac involvement is rare but has a poor prognosis. Biventricular hypertrophic cardiomyopathy is an exceptional finding in amyloidosis and its association with obstructive right ...
Hamza Sanoussi   +3 more
doaj   +1 more source

Etude de l'évolution des patients porteurs d'une cardiomyopathie hypertrophique obstructive (CMHO) après alcoolisation septale [PDF]

open access: yes, 2014
La cardiomyopathie hypertrophique (CMH) est la maladie cardiaque monogénique la plus fréquente, touchant environ 1 individu sur 500 dans la population (1,2).
CARREL, L.
core  

Home - About - Disclaimer - Privacy